Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 9 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Papatheodoridis, George V  [Clear All Filters]
Journal Article
Papatheodoridis, G. V., Cholongitas E., Archimandritis A. J., & Burroughs A. K. (2009).  Current management of hepatitis B virus infection before and after liver transplantation.. Liver Int. 29(9), 1294-305.
Kostas, A., Siakavellas S. I., Kosmidis C., Takou A., Nikou J., Maropoulos G., et al. (2017).  Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.. World J Gastroenterol. 23(41), 7387-7396.
Cholongitas, E., Haidich A-B., Apostolidou-Kiouti F., Chalevas P., & Papatheodoridis G. V. (2018).  Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review.. Ann Gastroenterol. 31(4), 480-490.
Cholongitas, E., Papatheodoridis G. V., Goulis J., Vlachogiannakos J., Karatapanis S., Ketikoglou J., et al. (2015).  The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.. Ann Gastroenterol. 28(1), 109-117.
Cholongitas, E., Papatheodoridis G. V., & Burroughs A. K. (2010).  Liver grafts from anti-hepatitis B core positive donors: a systematic review.. J Hepatol. 52(2), 272-9.
Papatheodoridis, G. V., Chrysanthos N., Cholongitas E., Pavlou E., Apergis G., Tiniakos D. G., et al. (2009).  Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.. J Hepatol. 51(5), 931-8.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Pipili, C. L., Papatheodoridis G. V., & Cholongitas E. C. (2013).  Treatment of hepatitis B in patients with chronic kidney disease.. Kidney Int. 84(5), 880-5.
Papatheodoridis, G. V., Manolakopoulos S., Touloumi G., Vourli G., Raptopoulou-Gigi M., Vafiadis-Zoumbouli I., et al. (2011).  Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece c. Gut. 60(8), 1109-16.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.